Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Aneurysmal Subarachnoid Haemorrhage
NCT00731627Phase 3Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jan 2007
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Placebo with Simvastatin (2 arms). Primary endpoint: Modified Rankin Disability Score at 6 months. Started Jan 2007; status: completed.
02
Drugs
simvastatin
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00731627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00731627.